Although better systolic BP control in the captopril group would have contributed to these findings, it was suggested that treatment with ACE inhibition can reverse the usually relentlessly progressive course of nephrotic range proteinuria in a subgroup of patients with T1DM. The gene discussed is ACE; the disease is type 1 diabetes mellitus.